Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 06 - 02 symbols : Bmy save search
Bristol Myers Squibb Announces Topline Results Showing Treatment with Orencia (abatacept) Improved Survival in People Hospitalized with COVID-19
Published: 2022-06-02 (Crawled : 16:00) - biospace.com/
BMY | $48.58 0.58% 2.6M
|
Health Technology
|
| O: 0.21%
H: 0.0%
C: 0.0%
covid-19 treatment topline results
Intensity Therapeutics' INT230-6 Demonstrates Increased Survival as Either Monotherapy or in Combination with Ipilimumab in Patients with Relapsed, Refractory, Metastatic Sarcomas
Published: 2022-06-02 (Crawled : 11:00) - prnewswire.com
BMY | $48.58 0.58% 2.6M
|
Health Technology
|
| O: 0.21%
H: 0.0%
C: 0.0%
int230
Global Alzheimer's Disease Treatment Markets, Analysis & Forecasts, 2016-2021, 2021-2026F, 2031F: Focus on Cholinergic, Memantine, Combined Drug, AChE inhibitors, Immunoglobulins
Published: 2022-06-02 (Crawled : 10:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -0.31%
H: 0.0%
C: 0.0%
TAK | News | $13.185 0.19% 430K
|
Health Technology
|
| O: -3.16%
H: 0.36%
C: -0.07%
NVS | $93.81 1.34% 1.2M
|
Health Technology
|
| O: -0.73%
H: 0.12%
C: 0.1%
LLY | $728.765 -2.3% 1.5M
|
Health Technology
|
| O: -0.9%
H: 0.0%
C: 0.0%
BMY | $48.58 0.58% 2.6M
|
Health Technology
|
| O: 0.21%
H: 0.0%
C: 0.0%
ABBV | News | $166.43 1.08% 2M
|
Health Technology
|
| O: -1.0%
H: 0.0%
C: 0.0%
treatment disease alzheimer's alzheimer’s
Gainers vs Losers
| 74% | 26% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.054 50.0% 290M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
NVFY | $2.71 28.44% 31M
|
Consumer Durables
ZCMD | $1.86 28.28% 29M
|
Commercial Services
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
INSG | $2.98 23.14% 190K
|
Electronic Technology
Your saved searches
Save your searches and get alerts when important news are released.